International Journal of Antimicrobial Agents
Volume 36, Issue 2 , Pages 155-158 , August 2010

In vitro efficacy of the combination of ciprofloxacin and cefotaxime against nalidixic acid-resistant Salmonella enterica serotype Typhi

  • Dong-Min Kim

      Affiliations

    • Division of Infectious Diseases, Department of Internal Medicine, Chosun University College of Medicine, Clinical Research Institute, Gwangju, South Korea
    • These two authors contributed equally to this work.
    • ,
  • Ganesh Prasad Neupane

      Affiliations

    • Division of Infectious Diseases, Department of Internal Medicine, Chosun University College of Medicine, Clinical Research Institute, Gwangju, South Korea
    • These two authors contributed equally to this work.
    • ,
  • Sook Jin Jang

      Affiliations

    • Department of Laboratory Medicine, Chosun University College of Medicine, Clinical Research Institute, Gwangju, South Korea
    • Corresponding Author InformationCorresponding author. Tel.: +82 62 220 3259; fax: +82 62 232 2063.
    • ,
  • Sung Hun Kim

      Affiliations

    • Division of Enteric Bacterial Infections, Center for Infectious Diseases, National Institute of Health, Seoul, South Korea
    • ,
  • Bok Kwon Lee

      Affiliations

    • Division of Enteric Bacterial Infections, Center for Infectious Diseases, National Institute of Health, Seoul, South Korea

Received 8 December 2009 ,Accepted 11 March 2010.

References 

  1. Parry CM, Ho VA, Phuong le T, Bay PV, Lanh MN, Tung LT, et al. Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin–azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. Antimicrob Agents Chemother. 2007;51:819–825
  2. Chau TT, Campbell JI, Galindo CM, Van Minh Hoang N, Diep TS, Nga TTT, et al. Antimicrobial drug resistance of Salmonella enterica serovar Typhi in Asia and molecular mechanism of reduced susceptibility to the fluoroquinolones. Antimicrob Agents Chemother. 2007;51:4315–4323
  3. Kariuki S, Revathi G, Muyodi J, Mwituria J, Munyalo A, Mirza S, et al. Characterization of multidrug-resistant typhoid outbreaks in Kenya. J Clin Microbiol. 2004;42:1477–1482
  4. Capoor MR, Nair D, Aggarwal P, Mathys V, Dehem M, Bifani PJ. Salmonella enterica serovar Typhi: molecular analysis of strains with decreased susceptibility and resistant to ciprofloxacin in India from 2001–2003. Braz J Infect Dis. 2007;11:423–425
  5. Dutta P, Mitra U, Dutta S, De A, Chatterjee MK, Bhattacharya SK. Ceftriaxone therapy in ciprofloxacin treatment failure typhoid fever in children. Indian J Med Res. 2001;113:210–213
  6. Basnyat B, Maskey AP, Zimmerman MD, Murdoch DR. Enteric (typhoid) fever in travelers. Clin Infect Dis. 2005;41:1467–1472
  7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Eighteenth informational supplement. Document M100-S18. Wayne, PA: CLSI; 2008.
  8. Kim DM, Lym Y, Jang SJ, Han H, Kim YG, Chung CH, et al. In vitro efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus. Antimicrob Agents Chemother. 2005;49:3489–3491
  9. Vidaillac C, Leonard SN, Sader HS, Jones RN, Rybak MJ. In vitro activity of ceftaroline alone and in combination against clinical isolates of resistant Gram-negative pathogens, including β-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2009;53:2360–2366
  10. Hopkins KL, Davies RH, Threlfall EJ. Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int J Antimicrob Agents. 2005;25:358–373
  11. Wain J, Hoa NT, Chinh NT, Vinh H, Everett MJ, Diep TS, et al. Quinolone-resistant Salmonella Typhi in Viet Nam: molecular basis of resistance and clinical response to treatment. Clin Infect Dis. 1997;25:1404–1410
  12. Parry C, Wain J, Chinh NT, Vinh H, Farrar JJ. Quinolone-resistant Salmonella Typhi in Vietnam. Lancet. 1998;351:1289
  13. Saha SK, Talukder SY, Islam M, Saha S. A highly ceftriaxone-resistant Salmonella Typhi in Bangladesh. Pediatr Infect Dis J. 1999;18:387
  14. Butler T, Frenck RW, Johnson RB, Khakhria R. In vitro effects of azithromycin on Salmonella Typhi: early inhibition by concentrations less than the MIC and reduction of MIC by alkaline pH and small inocula. J Antimicrob Chemother. 2001;47:455–458
  15. Butler T. Reduction of MIC of azithromycin for Salmonella Typhi and Staphylococcus aureus in broth exposed to previous growth of Salmonella Typhi. J Antimicrob Chemother. 2002;50:143–145

PII: S0924-8579(10)00155-X

doi: 10.1016/j.ijantimicag.2010.03.022

International Journal of Antimicrobial Agents
Volume 36, Issue 2 , Pages 155-158 , August 2010

Article Tools

* Image Usage & Resolution